Evaluating the Efficacy of EEG Neurofeedback Therapy in Managing ADHD and Anxiety: A Retrospective Analysis of 113 Cases
Archives of Clinical Trials · 30.12.2025 · 5 (2)
DOI: 10.33425/2768-4598.1054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Trials, online erschienen am 30.12.2025. Verfasst von Adrian Low und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
This study aimed to evaluate the efficacy of dynamical neurofeedback therapy as a nonpharmacological intervention for managing Attention Deficit Hyperactivity Disorder (ADHD) and anxiety disorders through comprehensive analysis of clinical outcomes. Design/Methodology/Approach: A retrospective analysis was conducted on 113 clinical cases (68 ADHD, 45 anxiety) who completed dynamical neurofeedback therapy using the NeurOptimal system between January-September 2025. Pre- and post-treatment assessments included standardized symptom ratings and qualitative data. Outcomes were compared across diagnostic groups.
Findings
Significant improvements were observed across all parameters: anxiety scores reduced from 7.2±1.4 to 5.0±1.2 (p
Zitieren
APA
Low, A., Lam, W. L., & Chau, K. T. (2025). Evaluating the Efficacy of EEG Neurofeedback Therapy in Managing ADHD and Anxiety: A Retrospective Analysis of 113 Cases. Archives of Clinical Trials, 5(2). https://doi.org/10.33425/2768-4598.1054
Vancouver
Low A, Lam WL, Chau KT. Evaluating the Efficacy of EEG Neurofeedback Therapy in Managing ADHD and Anxiety: A Retrospective Analysis of 113 Cases. Archives of Clinical Trials. 2025;5(2). doi:10.33425/2768-4598.1054
BibTeX
@article{Low2025,
author = {Low, Adrian and Lam, Wai Lun and Chau, Keng Tou},
title = {Evaluating the Efficacy of EEG Neurofeedback Therapy in Managing ADHD and Anxiety: A Retrospective Analysis of 113 Cases},
journal = {Archives of Clinical Trials},
year = {2025},
volume = {5},
number = {2},
doi = {10.33425/2768-4598.1054}
}
EUVIMED